Predicting response to Taxotere chemotherapy « THE "NEW" PROSTATE CANCER INFOLINK
Links shared publicly online about this topic.
- 1,610total visits
Predicting response to Taxotere chemotherapy « THE "NEW" PROSTATE CANCER INFOLINK
View full resource at prostatecancerinfolink.net
Tags: Cancer, Cancer Medication, Chemotherapy, Prostate Cancer, Prostate, Men's Health, Taxotere
Most Recently Shared on November 11, 2009 at 9:05 pm By:
Predicting response to Taxotere chemotherapy « THE "NEW" PROSTATE ... http://bit.ly/AbW5u
DNA marker predicts platinum drug response in breast, ovarian cancer - Dana-Farber Cancer Institute
dana-farber.org — “Dana-Farber and Brigham and Women’s researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at dana-farber.org
Most Recently Shared on March 24, 2012 at 10:30 pm By:
Discovery of genetic marker predicting response to platinum drugs in triple-negative #breastcancer http://t.co/IFMrAlTO
Predicting Response To Platinum Chemotherapy Via Marker Of DNA Damage - QualityPoint Technologies
qualitypointtech.net — “Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin. These drugs are widely used for ovarian cancer, but as with most cancer drugs, it can be difficult to predict who will respond to therapy. A team of researchers from the Dana-Farber Cancer Institute found that this marker, telomeric allelic imbalance or tAI, could predict sensitivity to therapy in patients with triple-negative breast cancer...” View full resource at qualitypointtech.net
Most Recently Shared on March 24, 2012 at 11:00 am By:
Predicting Response To Platinum Chemotherapy Via Marker Of DNA Damage: Scientists have uncovered a marker of DNA d... http://t.co/yKYetjXu
Predicting Response To Platinum Chemotherapy Via Marker Of DNA Damage
medicalnewstoday.com — “Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin.These drugs are widely used for ov” View full resource at medicalnewstoday.com
Most Recently Shared on March 24, 2012 at 7:05 am By:
Predicting Response To Platinum Chemotherapy Via Marker Of DNA Damage: Scientists have uncovered a marker of DNA... http://t.co/Ff81XZlL
Marker of DNA damage could predict response to platinum chemotherapy
labspaces.net — “Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin.” View full resource at labspaces.net
Most Recently Shared on March 23, 2012 at 1:45 pm By:
Marker of DNA damage could predict response to platinum chemotherapy - http://t.co/JuxvhvRs
Marker of DNA damage could predict response to platinum chemotherapy
ecancer.org — “Marker of DNA damage could predict response to platinum chemotherapy” View full resource at ecancer.org
Most Recently Shared on March 23, 2012 at 10:43 am By:
ecancer Oncology and Health News
Marker of DNA damage could predict response to platinum chemotherapy http://t.co/Zt5ne4gn #cancer
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 4:29 pm By:
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer: Brigham and Women's Hospital and Dana-Farb... http://t.co/6ciU9u4w
DNA marker predicts platinum drug response in breast, ovarian cancer
medicalxpress.com — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive 'triple negative' breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.” View full resource at medicalxpress.com
Most Recently Shared on March 22, 2012 at 2:45 pm By:
PhysOrg Health News Health News
DNA marker predicts platinum drug response in breast, ovarian cancer http://t.co/3Uu90Gwq
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 2:39 pm By:
newswise Health Communicator and Health News
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer http://t.co/Yf75k9xK
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 2:31 pm By:
#health news: DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer http://t.co/lGmyGKPG
DNA marker predicts platinum drug response in breast, ovarian cancer
eurekalert.org — “Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies. The marker, found on chromosomes within the cancer cells, flags breast and ovarian cancer cells that can't repair the type of DNA damage caused by treatment with platinum drugs, including cisplatin and carboplatin.” View full resource at eurekalert.org
Most Recently Shared on March 22, 2012 at 2:30 pm By:
From @DanaFarber : #DNA marker predicts platinum drug response in breast, ovarian #cancer. http://t.co/42uuDOZc
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer
newswise.com — “Brigham and Women's Hospital and Dana-Farber Cancer Institute researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at newswise.com
Most Recently Shared on March 22, 2012 at 2:25 pm By:
DNA Marker Predicts Platinum Drug Response in Breast, Ovarian Cancer: Brigham and Women's Hospital and D... http://t.co/65TshQMm #cancer
In Advanced Non-Small Cell Lung Cancer, CYFRA21-1 Might Be Predictive Marker
medicalnewstoday.com — “Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. Research” View full resource at medicalnewstoday.com
Most Recently Shared on March 19, 2012 at 7:05 am By:
In Advanced Non-Small Cell Lung Cancer, CYFRA21-1 Might Be Predictive Marker http://t.co/NyOsmDCZ #lungcancer
CYFRA21-1 might be predictive marker in advanced NSCLC
eurekalert.org — “Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's Journal of Thoracic Oncology shows that this marker can be used to determine whether or not a patient should continue a particular chemotherapy regimen.” View full resource at eurekalert.org
Most Recently Shared on March 16, 2012 at 6:58 am By:
CYFRA21-1 might be predictive marker in advanced NSCLC: (International Association for the Study of Lung Cancer)... http://t.co/dhAPov5G
CYFRA21-1 might be predictive marker in advanced NSCLC
medicalxpress.com — “Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) ...” View full resource at medicalxpress.com
Most Recently Shared on March 15, 2012 at 4:20 pm By:
PhysOrg Health News Health News
CYFRA21-1 might be predictive marker in advanced NSCLC http://t.co/IxOFuUXu
Oncology Medical Article | Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma
mdlinx.com — “Oncology Medical Article: Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma” View full resource at mdlinx.com
Most Recently Shared on March 14, 2012 at 5:25 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in ... http://t.co/cqWJeAQQ #oncology
Advertisement
